• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Pragmatic Free Trial Meta

Pragmatic Free Trial Meta is a free and non-commercial open data platform and infrastructure that supports research on pragmatic trials. It is a platform that collects and shares clean trial data and ratings using PRECIS-2 which allows for multiple and 프라그마틱 무료스핀 varied meta-epidemiological studies to evaluate the effect of treatment on trials with different levels of pragmatism and other design features.

Background

Pragmatic studies provide real-world evidence that can be used to make clinical decisions. The term "pragmatic", 프라그마틱 홈페이지 프라그마틱 정품 사이트확인 (mouse click on Amodei) however, is a word that is often used in contradiction and its definition and evaluation require further clarification. Pragmatic trials should be designed to inform policy and clinical practice decisions, rather than confirm a physiological or clinical hypothesis. A pragmatic trial should try to be as similar to the real-world clinical environment as possible, such as the recruitment of participants, setting and design as well as the implementation of the intervention, as well as the determination and analysis of outcomes and primary analyses. This is a significant difference between explanatory trials, as defined by Schwartz & Lellouch1 which are designed to test a hypothesis in a more thorough manner.

Truely pragmatic trials should not conceal participants or the clinicians. This can lead to a bias in the estimates of the effect of treatment. The trials that are pragmatic should also try to attract patients from a wide range of health care settings to ensure that the results can be applied to the real world.

Furthermore, trials that are pragmatic must be focused on outcomes that matter to patients, such as quality of life and functional recovery. This is particularly important in trials that involve invasive procedures or those with potentially dangerous adverse events. The CRASH trial29, for example, focused on functional outcomes to compare a 2-page case-report with an electronic system to monitor the health of patients in hospitals suffering from chronic heart failure. In addition, the catheter trial28 focused on urinary tract infections that are symptomatic of catheters as the primary outcome.

In addition to these features pragmatic trials should also reduce trial procedures and data-collection requirements to cut down on costs and time commitments. Additionally these trials should strive to make their results as relevant to actual clinical practices as possible. This can be achieved by ensuring that their analysis is based on an intention-to treat method (as described within CONSORT extensions).

Despite these criteria however, a large number of RCTs with features that defy the concept of pragmatism have been mislabeled as pragmatic and published in journals of all kinds. This can lead to misleading claims about pragmatism, and the use of the term should be standardized. The creation of the PRECIS-2 tool, which provides a standard objective assessment of pragmatic features is a great first step.

Methods

In a pragmatic research study, the goal is to inform clinical or policy decisions by showing how an intervention can be integrated into routine treatment in real-world situations. Explanatory trials test hypotheses concerning the causal-effect relationship in idealized environments. Therefore, pragmatic trials might be less reliable than explanatory trials and might be more susceptible to bias in their design, conduct, and analysis. Despite their limitations, pragmatic studies can be a valuable source of information to make decisions in the context of healthcare.

The PRECIS-2 tool measures the level of pragmatism that is present in an RCT by assessing it across 9 domains, ranging from 1 (very explicit) to 5 (very pragmatic). In this study, the areas of recruitment, organisation, flexibility in delivery, flexibility in adherence, and follow-up were awarded high scores. However, the primary outcome and the method of missing data was scored below the pragmatic limit. This suggests that it is possible to design a trial using good pragmatic features without damaging the quality of its results.

It is difficult to determine the degree of pragmatism that is present in a trial because pragmatism does not have a single attribute. Some aspects of a research study can be more pragmatic than other. Additionally, logistical or protocol modifications during the course of a trial can change its score on pragmatism. Koppenaal and colleagues found that 36% of the 89 pragmatic studies were placebo-controlled or conducted prior to licensing. Most were also single-center. They aren't in line with the norm, and can only be considered pragmatic if their sponsors agree that these trials are not blinded.

A common feature of pragmatic research is that researchers try to make their findings more relevant by studying subgroups of the trial sample. However, this often leads to unbalanced results and lower statistical power, which increases the risk of either not detecting or misinterpreting differences in the primary outcome. This was a problem during the meta-analysis of pragmatic trials as secondary outcomes were not corrected for covariates' differences at the time of baseline.

Additionally, pragmatic trials can also have challenges with respect to the collection and interpretation of safety data. This is because adverse events are generally reported by the participants themselves and are susceptible to reporting delays, inaccuracies or coding deviations. It is important to increase the accuracy and quality of the results in these trials.

Results

Although the definition of pragmatism doesn't require that clinical trials be 100% pragmatist, there are benefits when incorporating pragmatic components into trials. These include:

By including routine patients, the results of the trial can be translated more quickly into clinical practice. However, pragmatic trials have disadvantages. The right type of heterogeneity, like could help a study extend its findings to different patients or settings. However the wrong kind of heterogeneity can reduce the assay sensitivity and thus lessen the power of a trial to detect minor treatment effects.

Several studies have attempted to classify pragmatic trials using a variety of definitions and scoring methods. Schwartz and Lellouch1 have developed a framework that can distinguish between explanatory studies that confirm a physiological hypothesis or clinical hypothesis, and pragmatic studies that inform the choice for appropriate therapies in the real-world clinical practice. Their framework comprised nine domains, each scoring on a scale ranging from 1-5, with 1 indicating more explanatory and 5 indicating more pragmatic. The domains were recruitment, setting, intervention delivery, flexible adherence, follow-up and primary analysis.

The original PRECIS tool3 was an adapted version of the PRECIS tool3 that was based on the same scale and domains. Koppenaal et al10 developed an adaptation of this assessment, known as the Pragmascope, that was easier to use for systematic reviews. They found that pragmatic systematic reviews had higher average scores in the majority of domains, with lower scores in the primary analysis domain.

This distinction in the primary analysis domain could be explained by the fact that most pragmatic trials analyze their data in the intention to treat manner, whereas some explanatory trials do not. The overall score was lower for systematic reviews that were pragmatic when the domains on organisation, flexible delivery, and follow-up were combined.

It is important to note that a pragmatic trial does not necessarily mean a low-quality trial, and there is a growing number of clinical trials (as defined by MEDLINE search, however this is neither specific or sensitive) that employ the term "pragmatic" in their title or abstract. The use of these terms in abstracts and titles could suggest a greater awareness of the importance of pragmatism, but it is unclear whether this is reflected in the content of the articles.

Conclusions

In recent times, pragmatic trials are gaining popularity in research as the importance of real-world evidence is increasingly recognized. They are clinical trials that are randomized that compare real-world care alternatives instead of experimental treatments in development. They involve patient populations which are more closely resembling the patients who receive routine medical care, they utilize comparisons that are commonplace in practice (e.g. existing medications), and they depend on participants' self-reports of outcomes. This approach can overcome the limitations of observational research, for example, the biases associated with the reliance on volunteers and the limited availability and the coding differences in national registry.

Pragmatic trials have other advantages, like the ability to use existing data sources and a higher chance of detecting significant distinctions from traditional trials. However, these trials could have some limitations that limit their validity and generalizability. The participation rates in certain trials may be lower than anticipated because of the healthy-volunteering effect, financial incentives, or 프라그마틱 무료스핀 competition from other research studies. A lot of pragmatic trials are restricted by the necessity to enroll participants quickly. Additionally, some pragmatic trials lack controls to ensure that the observed differences aren't due to biases in the conduct of trials.

The authors of the Pragmatic Free Trial Meta identified RCTs published up to 2022 that self-described as pragmatism. They assessed pragmatism using the PRECIS-2 tool, which includes the eligibility criteria for domains, recruitment, flexibility in adherence to interventions, and follow-up. They found 14 trials scored highly pragmatic or pragmatic (i.e. scoring 5 or higher) in at least one of these domains.

Trials with high pragmatism scores are likely to have more lenient criteria for 프라그마틱 슬롯버프 eligibility than conventional RCTs. They also contain populations from many different hospitals. The authors suggest that these characteristics could make pragmatic trials more effective and useful for everyday practice, but they do not necessarily guarantee that a trial conducted in a pragmatic manner is free from bias. The pragmatism is not a fixed characteristic; a pragmatic test that does not have all the characteristics of an explicative study can still produce reliable and beneficial results.